AEVI GENOMIC MEDICINE, INC.
Profile
Company Names
AEVI GENOMIC MEDICINE, INC.
MEDGENICS, INC.
Addresses
435 DEVON PARK DRIVE,, SUITE 715, WAYNE, PA 19087
435 DEVON PARK DRIVE, BLDG. 700, WAYNE, PA 19087
555 CALIFORNIA STREET, SUITE 365, SAN FRANCISCO, CA 94104
TERADION BUSINESS PK., MISGAV, L3 20179
Phone Numbers
610-254-4201
415-568-2245
1-646-239-1690
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY
Year Incorporated:
> 5 years ago
State Incorporated:
DELAWARE
Total Amount Raised:
$45,426,066.00
Number of Funding Rounds:
6
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
6
2017-10-17
$28,000,000.00
$28,000,000.00
$0.00
Equity
5
2015-10-06
$3,200,000.00
$3,200,000.00
$0.00
Equity
4
2012-06-18
$9,529,196.00
$9,529,382.00
$186.00
Equity
3
2010-09-22
$4,001,500.00
$4,001,500.00
$0.00
Debt
2
2010-05-25
$430,370.00
$430,370.00
$0.00
Equity
1
2009-06-16
$265,000.00
$5,000,000.00
$4,735,000.00
Debt
People
First Name
Middle Name
Last Name
Titles
Related Companies
SOL
J.
BARER
DIRECTOR
ISAAC
BLECH
DIRECTOR
SOCIALWISE, INC. (FORMERLY KNOWN AS IDEAEDGE, INC)
| CONTRAFECT CORP
| BILLMYPARENTS, INC.
| CERECOR INC.
| MEDGENICS, INC.
| PREMIER ALLIANCE GROUP, INC.
| EDGE THERAPEUTICS, INC.
| SPENDSMART PAYMENTS CO
| CENTREXION CORP
| RESTORGENEX CORP
| ROOT9B TECHNOLOGIES INC.
| WAVEGUIDE CORP
| X4 PHARMACEUTICALS, INC.
| ROOT9B TECHNOLOGIES, INC.
| INSPIREMD, INC.
| CENTREXION THERAPEUTICS CORP
| SAPIENCE THERAPEUTICS, INC.
| ARIDIS PHARMACEUTICALS, INC.
| X-VAX TECHNOLOGY, INC.
| REGENOVATION, INC.
| DIFFUSION PHARMACEUTICALS INC.
| NACUITY PHARMACEUTICALS, INC.
| ELUCIDA ONCOLOGY, INC.
| MARINA BIOTECH, INC.
| ALVEO TECHNOLOGIES INC.
| VEDANTRA PHARMACEUTICALS, INC.
MICHAEL
F.
COLA
EXECUTIVE OFFICER, DIRECTOR
BARBARA
DUNCAN
DIRECTOR
BRIAN
PIPER
EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
NO REVENUES
Equity
2017-10-17
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2015-10-06
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2012-06-18

